
HelioFlux is pioneering a transformative approach to cancer detection and treatment by leveraging quantum mechanics, biophysics, and AI. Their technology platform measures subtle changes in cell light emissions to detect cancer at its earliest stages, before tumors grow too large. They have developed a functional prototype for human head detection and validated it on cell and animal models, alongside software that analyzes over a million data points per scan for real-time, accurate results. HelioFlux is poised to lead the next generation of healthcare with a non-invasive, radiation-free, and cost-effective solution that aims to significantly improve patient outcomes. The company has been accepted into NVIDIA's Inception Program, gaining access to technical resources to scale their AI-driven platform.

HelioFlux is pioneering a transformative approach to cancer detection and treatment by leveraging quantum mechanics, biophysics, and AI. Their technology platform measures subtle changes in cell light emissions to detect cancer at its earliest stages, before tumors grow too large. They have developed a functional prototype for human head detection and validated it on cell and animal models, alongside software that analyzes over a million data points per scan for real-time, accurate results. HelioFlux is poised to lead the next generation of healthcare with a non-invasive, radiation-free, and cost-effective solution that aims to significantly improve patient outcomes. The company has been accepted into NVIDIA's Inception Program, gaining access to technical resources to scale their AI-driven platform.